Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preference Evaluation of Nasonex vs Flonase in Allergic Rhinitis
NCT00783458Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2004
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of mometasone furoate nasal spray in allergic rhinitis (AR) (2 arms), sponsored by Organon & Co. Primary endpoint: Overall product preference at Day 1. Started Dec 2004; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00783458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783458.